GlaxoSmithKline plc (GSK) (NYSE: GSK) has completed its acquisition of Stiefel Laboratories, Inc. GSK has acquired the total share capital ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE